CG Invites
We strive to be a global biopharma leader whose mission is
to develop innovative, life-changing medicine
Pipeline
CG-652
-
Indication
Rheumatoid arthritis
-
Development stage
Phase 1 clinical study in progress
-
Mechanism of action and features
- Effective suppression of pain and inflammation in rheumatic diseases
- Confirmation of synergistic effect when two drugs are used in combination in non-clinical experiments
- Oral combination drug under development
CG-652